Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

STORM trial to identify genetic variability in metastatic breast cancer

Dr David Cox - Cancer Research Center of Lyon, Lyon, France
STORM trial to identify genetic variability in metastatic breast cancer ( Dr David Cox - Cancer Research Center of Lyon, Lyon, France )
9 Sep 2017

The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer

Dr Paul Cottu - Institut Curie, Paris, France
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer ( Dr Paul Cottu - Institut Curie, Paris, France )
9 Sep 2017

STAMPEDE: Abiraterone acetate plus prednisolone or docetaxel

Matthew Sydes - Medical Research Council, London, UK
STAMPEDE: Abiraterone acetate plus prednisolone or docetaxel ( Matthew Sydes - Medical Research Council, London, UK )
9 Sep 2017

Problems with care: a patients perspective

Ana Kogan Wais - Ewing sarcoma patient, Madrid, Spain
Problems with care: a patients perspective ( Ana Kogan Wais - Ewing sarcoma patient, Madrid, Spain )
9 Sep 2017

Reduced work ability in cancer survivors

Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway
Reduced work ability in cancer survivors ( Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway )
9 Sep 2017

Problems with survivorship care in Europe

Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy
Problems with survivorship care in Europe ( Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy )
9 Sep 2017

Underprovision and inequality of specialised cancer care

Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece
Underprovision and inequality of specialised cancer care ( Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece )
9 Sep 2017

Regorafenib versus lomustine for relapsed glioblastoma

Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy
Regorafenib versus lomustine for relapsed glioblastoma ( Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy )
9 Sep 2017

Reviewing LORELEI, mindACT and ExteNET trials in breast cancer

Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer ( Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain )
9 Sep 2017

Questioning the role of CT-scan in NSCLC post-surgery follow-up

Prof Virginie Westeel - University of Franche-Comté, Besançon, France
Questioning the role of CT-scan in NSCLC post-surgery follow-up ( Prof Virginie Westeel - University of Franche-Comté, Besançon, France )
9 Sep 2017

Osimertinib suitable for first line EGFRm lung cancer

Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA
Osimertinib suitable for first line EGFRm lung cancer ( Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA )
9 Sep 2017

FLAURA study of osimertinib versus TKI for 1st line NSCLC

Dr Suresh Ramalingam - Winship Cancer Institute, Druid Hills, USA
FLAURA study of osimertinib versus TKI for 1st line NSCLC ( Dr Suresh Ramalingam - Winship Cancer Institute, Druid Hills, USA )
9 Sep 2017